Aleva Neurotherapeutics' Series B Round

Aleva Neurotherapeutics raised a round of funding on April 11, 2012. Investors include Banexi Ventures.

Aleva Neurotherapeutics develops next-generation implants for Deep Brain Stimulation (DBS) therapy that are designed to be versatile, more precise and efficient than currently available DBS approaches…

Articles about Aleva Neurotherapeutics' Series B Round: